Management of Advanced Pulmonary Sarcoidosis.
advanced pulmonary sarcoidosis
advanced sarcoidosis
pulmonary fibrosis
sarcoidosis
sarcoidosis-associated pulmonary hypertension
Journal
American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
pubmed:
24
11
2021
medline:
23
4
2022
entrez:
23
11
2021
Statut:
ppublish
Résumé
The term "advanced sarcoidosis" is used for forms of sarcoidosis with a significant risk of loss of organ function or death. Advanced sarcoidosis often involves the lung and is described as "advanced pulmonary sarcoidosis" (APS), which includes advanced pulmonary fibrosis, associated complications such as bronchiectasis and infections, and pulmonary hypertension. Although APS affects a small proportion of patients with sarcoidosis, it is the leading cause of poor outcomes, including death. Here we review the major patterns of APS with a focus on the current management as well as potential approaches for improved outcomes for this most serious sarcoidosis phenotype.
Identifiants
pubmed: 34813386
doi: 10.1164/rccm.202106-1366CI
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM